Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020118045 - INJECTABLE FORMULATIONS

Publication Number WO/2020/118045
Publication Date 11.06.2020
International Application No. PCT/US2019/064669
International Filing Date 05.12.2019
IPC
A61K 31/423 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
42Oxazoles
423condensed with carbocyclic rings
A61K 31/47 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
47Quinolines; Isoquinolines
A61P 27/02 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
27Drugs for disorders of the senses
02Ophthalmic agents
CPC
A61K 31/423
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
42Oxazoles
423condensed with carbocyclic rings
A61K 31/47
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
47Quinolines; Isoquinolines
A61P 27/02
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
27Drugs for disorders of the senses
02Ophthalmic agents
Applicants
  • ALDEYRA THERAPEUTICS, INC. [US]/[US]
Inventors
  • MACHATHA, Stephen Gitu
  • MACDONALD, Susan
Agents
  • REID, Andrea L.C.
  • ARICO, Joseph W.
  • FLEMING, Paul R.
  • OH, Euk Charlie
  • NIHAN, Danielle M.
  • PRAIRIE, Nicholas
  • DAVIS, Chad E.
  • STEVENSON, Christian
  • DECHERT LLP
Priority Data
62/775,77905.12.2018US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) INJECTABLE FORMULATIONS
(FR) FORMULATIONS INJECTABLES
Abstract
(EN)
The present disclosure relates to therapeutic compounds and formulations for treating, reducing the risk of, or for preventing a disease, disorder, or condition characterized by the presence of toxic aldehydes.
(FR)
La présente invention concerne des composés thérapeutiques et des formulations pour le traitement, la réduction du risque ou pour la prévention d'une maladie, d'un trouble ou d'un état pathologique caractérisé par la présence d'aldéhydes toxiques.
Latest bibliographic data on file with the International Bureau